You are here

Our science / Clinical Trials / Find a Trial / NCT00689351

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea

Back to Search Print Save as PDF Bookmark Trial

NCT00689351

Last updated on February 21, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Incheon, Bupyeong-gu, 400-711 Korea, Republic of
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pneumococcal Vaccine
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
42-98 days
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy 2-month-old-infants (42 to 98 days)

- Available for the entire study period (14 months)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Previous vaccine with pneumococcal, diptheria, tetanus, pertussis, polio or Hib
vaccine

- A previous severe reaction to any vaccine or vaccine-related component

NCT00689351
Pfizer
Completed
Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Pneumococcal Vaccines, Pneumococcal Conjugate Vaccine Vaccines
Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children
NCT00580684
All Genders
Pneumococcal Vaccines
Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants
NCT00366899
All Genders
0+
Years
Multiple Sites
Pneumococcal Vaccines
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.
NCT00368966
All Genders
0+
Years
Multiple Sites
Pneumococcal Vaccines
Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS
NCT00574548
All Genders
60+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now